Loading clinical trials...

Pharmacokinetic (PK) Evaluation of Nalmefene Formulations | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT07543276

Pharmacokinetic (PK) Evaluation of Nalmefene Formulations

This study is designed to characterize the PK of nalmefene following IV bolus and IM injections using nalmefene 0.5 mg (0.94% MgCl2) and IV bolus of 0.5 mg nalmefene hydrochloride injection in healthy...

Lead sponsor: Knoa Pharma LLC•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

A Bundled Intervention

NCT06593093 · Opioid Use Disorder, Opioid Overdose

RECRUITINGNA

A Model to Save Lives Through a Volunteer First Responder Service Providing Antidote Treatment in Opioid Overdose

NCT07079241 · Opioid Overdose

WITHDRAWN

Measures to Improve Outcomes After an Opioid Overdose

NCT03968237 · Opioid Overdose

COMPLETEDPhase 1

Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults

NCT05377255 · Opioid Overdose

Not Yet Recruiting

Evaluation of Clinical Decision Support in Opioid Tapering

NCT06527079 · Medication Abuse, Harm Reduction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 5, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment13

Start dateFeb 2026

Last updatedJun 5, 2026

Condition

Opioid Overdose

Locations shown

Ohio Clinical Trials

Columbus, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions